Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology-Reference-Cited by-同舟云学术

Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology

Published:2013-04-18 Issue:1 Volume:162 Page:141-144
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

van Kooten Niekerk Peter Buur¹,Roug Anne Stidsholt¹,Petersen Charlotte Christie²,Ommen Hans Beier¹,Kjeldsen Eigil¹,Bendix Knud³,Nyvold Charlotte Guldborg¹,Nederby Line¹,Hokland Peter¹

Affiliation:

1. Department of Haematology; Aarhus University Hospital; Aarhus; Denmark

2. The FACS Core Facility; Aarhus University; Aarhus; Denmark

3. University Institute of Pathology; Aarhus University Hospital; Aarhus; Denmark

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12339/fullpdf

Reference8 articles.

1. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia;Chávez-González;Leukemia Research,2004

2. Philadelphia chromosome-positive thrombocythemia without features of chronic myeloid leukemia (CML) in peripheral blood;Girodon;Annals of Hematology,2005

3. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis;Jallades;Leukemia Research,2008

4. JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia;Krämer;The Lancet Oncology,2007

5. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia;Michiels;Annals of Hematology,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors;OncoTargets and Therapy;2017-07

2. Dasatinib/imatinib/nilotinib;Reactions Weekly;2015-01